(Q43564921)

24 November 2017

title

Decreased corticotropin-releasing hormone (CRH) concentrations in the cerebrospinal fluid of eucortisolemic suicide attempters (English)

1 reference

24 November 2017

0 references

Brunner J

1

1 reference

24 November 2017

Stalla GK

2

1 reference

24 November 2017

Stalla J

3

1 reference

24 November 2017

Uhr M

4

1 reference

24 November 2017

Grabner A

5

1 reference

24 November 2017

Wetter TC

6

1 reference

24 November 2017

Bronisch T

7

1 reference

24 November 2017

publication date

1 January 2001

1 reference

Journal of Psychiatric Research

24 November 2017

published in

1 reference

24 November 2017

volume

35

1 reference

24 November 2017

issue

1

1 reference

24 November 2017

page(s)

1-9

1 reference

Elevated CSF CRF in suicide victims

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900007-3

CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900007-3

CSF corticotropin-releasing hormone and somatostatin in major depression: response to antidepressant treatment and relapse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900007-3

Cerebrospinal fluid studies of bipolar patients with and without a history of suicide attempts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900007-3

[Neurobiological correlates of suicidal behavior]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900007-3

Plasma corticotropin-releasing factor in depressive disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900007-3

Corticotropin-releasing factor immunoreactivity in post-mortem brain from depressed suicides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900007-3

Association of fluoxetine treatment with reductions in CSF concentrations of corticotropin-releasing hormone and arginine vasopressin in patients with major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900007-3

Cerebrospinal fluid corticotropin-releasing factor increases following haloperidol withdrawal in chronic schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900007-3

CSF corticotropin-releasing factor-like immunoactivity in chronic pain patients with and without major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900007-3

Low cerebrospinal fluid corticotropin-releasing hormone concentrations in eucortisolemic depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900007-3

Cerebrospinal fluid concentrations of corticotropin-releasing hormone, vasopressin, and somatostatin in depressed patients and healthy controls: response to amitriptyline treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900007-3

The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900007-3

Corticotropin-releasing factor binding sites in cortex of depressed suicides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900007-3

Chlordiazepoxide attenuates stress-induced accumulation of corticotropin-releasing factor mRNA in the paraventricular nucleus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900007-3

Chlordiazepoxide attenuates stress-induced activation of neurons, corticotropin-releasing factor (CRF) gene transcription and CRF biosynthesis in the paraventricular nucleus (PVN)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900007-3

A diurnal rhythm in cerebrospinal fluid corticotrophin-releasing hormone different from the rhythm of pituitary-adrenal activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900007-3

In vitro and in vivo effects of the triazolobenzodiazepine alprazolam on hypothalamic-pituitary-adrenal function: pharmacological and clinical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900007-3

Cerebrospinal Fluid Immunoreactive Cortieotropin-Releasing Hormone and Adrenocorticotropin Secretion in Cushing's Disease and Major Depression: Potential Clinical Implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900007-3

Diurnal variation of cerebrospinal fluid immunoreactive corticotropin-releasing hormone levels in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900007-3

Corticotropin-releasing factor, norepinephrine, and stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900007-3

Benzodiazepines attenuate the pituitary‐adrenal responses to corticotrophin‐releasing hormone in healthy volunteers, but not in patients with Cushing's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900007-3

Cortical concentrations of corticotropin-releasing hormone and its receptor in Alzheimer type dementia and major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900007-3

The dexamethasone suppression test as an indicator of suicide: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900007-3

Long-term intracerebroventricular infusion of corticotropin-releasing hormone alters neuroendocrine, neurochemical, autonomic, behavioral, and cytokine responses to a systemic inflammatory challenge.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900007-3

Localization and quantification of pro-opiomelanocortin mRNA and glucocorticoid receptor mRNA in pituitaries of suicide victims

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900007-3

A.E. Bennett Research Award. Regulation of serotonin1A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: implications for the neurobiology of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900007-3

Hypothalamic-pituitary-adrenal and -thyroid axis dysfunctions and decrements in the availability of L-tryptophan as biological markers of suicidal ideation in major depressed females

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900007-3

Urinary catecholamines and cortisol in parasuicide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900007-3

The neurobiology of suicide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900007-3

Differential effects of haloperidol on the rat pituitary: decreased biosynthesis, processing and release of anterior lobe pro-opiomelanocortin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900007-3

Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900007-3

The effects of alprazolam on corticotropin-releasing factor neurons in the rat brain: implications for a role for CRF in the pathogenesis of anxiety disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900007-3

Effects of carbamazepine on pituitary-adrenal function in healthy volunteers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900007-3

Cerebrospinal fluid corticotropin-releasing hormone, vasopressin, and oxytocin concentrations in treated patients with major depression and controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900007-3

Hypothalamic-pituitary-adrenal axis function and platelet serotonin concentrations in depressed patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900007-3

Effects of corticotropin-releasing factor on brain serotonergic activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900007-3

Hypothalamic-pituitary-adrenocortical axis changes in the rat after long-term treatment with the reversible monoamine oxidase-A inhibitor moclobemide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900007-3

Corticotropin releasing factor administered into the ventricular CSF stimulates the pituitary-adrenal axis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900007-3

Hypothalamic-pituitary-adrenal axis function and suicidal behavior in depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900007-3

Neuropeptides in relation to suicidal behavior in depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900007-3

CSF corticotropin-releasing hormone in depressed patients and normal control subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900007-3

Hypothalamic-pituitary-adrenal axis and monoamine transmitter activity in depression: A pilot study of central and peripheral effects of electroconvulsive therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900007-3

Corticotropic-releasing hormone and serotonin interact in the human brainstem: behavioral implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900007-3

Chronic administration of the triazolobenzodiazepine alprazolam produces opposite effects on corticotropin-releasing factor and urocortin neuronal systems.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900007-3

Differential steroid hormone and neural influences on peptide mRNA levels in CRH cells of the paraventricular nucleus: a hybridization histochemical study in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900007-3

Corticotropin-releasing factor in humans. I. CRF stimulation in normals and CRF radioimmunoassay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900007-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900007-3

Forebrain pathways mediating stress-induced hormone secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900007-3

Alterations of corticotropin releasing hormone (CRH) and neuropeptide Y (NPY) plasma levels in mood disorder patients with a recent suicide attempt

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900007-3

10.1016/S0022-3956(01)00007-3

7 January 2021

Identifiers

DOI

1 reference

24 November 2017

1 reference